New hope for tough cancers: experimental drug targets advanced solid tumors
Disease control
Recruiting now
This study tests an experimental drug called GV20-0251 in adults with advanced solid tumors (like lung, head and neck, or colon cancer) that no longer respond to approved therapies. The goal is to see if the drug can shrink or control the tumors. About 350 participants will take …
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC